Druq approval process
Executive Summary
FDA Associate Com-.for Management and Operations Gerald Meyer has been given a temporary collateral assignment to assist in streamlining the drug approval process. Deputy Com. Norris announced the appointment at an FDA policy board meeting July 12. During Meyer's assignment, which is for an unspecified time period, Deputy Associate Com. for Management and Operations Sharon Smith Holston will assume day-to-day duties of Associate Com.